DMTKQ — DermTech Balance Sheet
0.000.00%
- $0.00m
- -$38.93m
- $15.30m
Annual balance sheet for DermTech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 March 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.03 | 63.8 | 225 | 126 | 55.9 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | 1.48 | 3.85 | 4.17 | 2.58 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.082 | 66.9 | 233 | 136 | 61.8 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | 2.73 | 12.3 | 62.4 | 56.7 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 12.4 | 69.8 | 248 | 202 | 122 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6.59 | 5.42 | 12.2 | 15.6 | 13.4 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 6.59 | 6.29 | 18.6 | 69.7 | 64.8 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 5.85 | 63.5 | 230 | 132 | 57.2 |
Total Liabilities & Shareholders' Equity | 12.4 | 69.8 | 248 | 202 | 122 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |